Article
Critical appraisal of genotype assessment in molybdenum cofactor deficiency.
Journal of inherited metabolic disease - 1 Nov 2017
Hinderhofer Katrin, Mechler Konstantin, Hoffmann Georg F, Lampert Anette, Mountford William K, Ries Markus
Abstract excerpt
INTRODUCTION: Molybdenum cofactor deficiency (MoCD) is an ultra-orphan, life-threatening disease. Substrate substitution therapy has successfully been performed in single cases of MoCD type A and clinical trials are underway for drug registration. We present an innovative approach for classification of genotype severity to test the hypothesis that milder sequence variants in MoCD result in a less severe disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
